このタブにカテゴリーはありません

CRODA

629

4.1(79)

会社概要

正式社名: CRODA
国際名称: Croda International Plc
ブランド名 / 商号: Croda Pharma
登録国: China
住所: China Mainland Shanghai Shanghai Room 701-703, Block C, Oriental Guoxin Business Plaza, No. 388 Fuquan North Road, Changning District, Shanghai
設立年: 1925

説明:

Founded in the UK in 1925, Croda is a globally established supplier of high-purity pharmaceutical excipients, vaccine adjuvants, and novel liposomes to leading pharmaceutical companies, universities, and research institutes, operating across small-molecule delivery, protein delivery, vaccine nucleic acid delivery, and vaccine adjuvant technology platforms. Its portfolio includes the Super Refined Polysorbate and Poloxamer 188 excipient lines, the PHAD synthetic MPLA and other vaccine adjuvants developed over more than 80 years, and the Avanti Lipids range of GMP-grade lipids, which supplied key lipid nanoparticle excipients for Pfizer's first COVID-19 mRNA vaccine in 2020. Manufacturing bio products and pharmaceutical excipients and selling worldwide, Croda combines its China operations (based in Shanghai) with global reach, and is recognized for its brand, international certifications, experienced R&D personnel, production capacity, rich product line, and high-quality service.